New Findings in Type 1 Diabetes Described from Department of Biomedical Sciences [Identifying Promising Immunomodulators for Type 1 Diabetes (T1D) and Islet Transplantation].

The article discusses new research on Type 1 Diabetes (T1D) focusing on immunomodulators for beta cell restoration and autoimmune response suppression. It highlights investigational drugs like teplizumab and other immunomodulators tested in clinical trials for T1D treatment and islet transplantation. The research provides insights into the mechanism of action, trial results, adverse effects, and ongoing clinical trials for these immunomodulators. The study aims to identify promising therapies for T1D and islet transplantation. [Extracted from the article]